Dag Morten Dalen Provost and professor of economics Personal Date of birth: April 19, 1966. Nationality: Norwegian. Married, two children. Education Cand. oecon, Department of Economics, University of Oslo, 1991. Dr. polit. in Economics, University of Oslo, 1996. (Title of thesis: Four essays on the theory of regulation). Academic positions Provost, BI Norwegian Business School. 2010-. Professor of Economics, BI Norwegian Business School. 2004-. Other academic experience Associate Dean, Bachelor and Master of Science program in Business and Economics (Siviløkonom-program). BI. 2005-2010. Scientific advisor (part time), Ragnar Frisch Centre for Economic Research. 2003-2008. Advisor (part-time), Central Bank of Norway. Financial stability wing. 1999-2000. Associate Professor. BI. 1998-2004. Researcher, Foundation for research in economics and business administration. SNF. 1996-98. Research fellow, Department of Economics. University of Oslo. 1992-1996. Lecturer, University of Botswana (Summer School). 1994. 1
Professional honors Member of the Board of Nye Veier AS. 2015. President of Norwegian Network for Private Higher Education. 2016 -. Chair of European Advisory Council of the Association to Advance Collegiate Schools of Business (AACSB). 2016-. Member of European Advisory Council of the Association to Advance Collegiate Schools of Business (AACSB). 2014-2016. Member of International Professional and Academic Advisory Board (IPAAB) of LUISS Business School, Rome. 2014-. Member of the National Committee for Evaluation of Professorships in Economics. 2007-2009. Elected board member. BI. 2004-2008. Reelected in 2006. Member of Norwegian Ministry of Administration and Labour Expert Commission on Competition between Public and Private Enterprises. 2004-2005 Advisor (full time) to the Parliamentary Inquiry Commission for the Norwegian Banking Crisis, The Norwegian Parliament (Stortinget). 1997-98. Other experiences Consultant for various private companies, ministries and governmental agencies. Expert witness and expert judge in court. Research Interests Industrial organization (empirical and theoretical). Regulation of public services health care, transportation and energy. Selected projects with project manager responsibilities Biopharma in European hospitals. Norwegian Research Council. 2010-2013. 4,8 mill. NOK Samfunnsøkonomiske gevinster av fotball-em. Norges Fotballforbund. 2009. (Consulting) Procurement of biopharma in Norwegian hospitals. Abbott Norway. 2009. (Consulting). 2
Economic regulation of district-heating in Norway. Ministry of Petroleum and Energy. 2007. 0.5 mill. NOK. Public procurement of passenger rail transport. Norwegian National Rail Administration. 2006. (Consulting). Integrating cost of interruption in revenue-cap regulation. NVE - Norwegian Water Resources and Energy Administration. 2006. (Consulting) Regulation of infrastructure: Electricity and gas. Norwegian Research Council and EBL. 2005-2006. 0.8 mill. NOK. Competition for innovation. Ministry of Modernization. 2005. 0.5 mill. NOK Concept - Front-end Management of Major Investment. Ministry of Finance. 2002-2004 (Frisch centre). Regulation of energy utilities and the development of new and efficient energy sources for the future. Norwegian Research Council and NVE. 2003-2006. 5,1 mill. NOK. Price regulation of pharmaceuticals. Norwegian Medicines Agency. 2003. (Frisch centre). Competition in the market for pharmaceuticals after deregulation. Ministry of Finance. 2002. 0.2 mill. NOK. An empirical study of the market for pharmaceuticals in Norway. Norwegian Research Council. 2002-2003. 0.5 mill. NOK Private or public ownership: Contracts, incentives and efficiency. Norwegian Research Council. 1998-2002. 2.5 mill. NOK. Publications In English 1. Dalen, D. M., M. Locatelli, E. Sorisio og S. Strøm (2014): Does the Identity of the Third-Party Payer Matter for Prescribing Doctors? Applied Economics and Finance. 2. Brekke, K. R., D. M. Dalen and T-H. Holmås (2013): Diffusion of pharmaceuticals: cross-country evidence of anti-tnf drugs. The European Journal of Health Economics. 3. Brekke, K. R., D. M. Dalen and S. Strøm (2012): Should pharmaceutical costs be curbed? Nordic Economic Policy Review. 4. Dalen, D. M. and E. R. Moen (2012): Ownership and cost-sharing contracts. 3
Australian Economic Papers. 5. Dalen, D.M. K. Furu, M. Locatelli and S. Strøm (2011): Generic substitution: Evidence from a new individual patient-doctor database. European Journal of Health Economics. 6. Dalen, D.M. and S. Strøm (2006): The pharmaceutical market in Norway. In Competition and Welfare - the Norwegian Experience by L. Sørgard (ed.). The Norwegian Competition Authority. 7. Dalen, D.M., S. Strøm and T. Haabeth (2006): Price regulation and generic competition in the pharmaceutical market. European Journal of Health Economics, 7, 208-214. 8. Dalen, D.M., E. R. Moen and C. Riis (2006): Contract renewal and incentives in public procurement. International Journal of Industrial Organization, 24, 269-285. 9. Dalen, D.M., Nils-Henrik M. von der Fehr, and Espen Moen (2003): Regulation under Wage Bargaining. Economic Journal, 113, 525-538. 10. Dalen, D.M., and Andres Gomez-Lobo (2003): Yardsticks on the road: Regulatory contracts and cost efficiency in the Norwegian Bus Industry. Transportation, 30, 371-386. 11. Dalen, D.M., E. R. Moen and C. Riis (2001): Public ownership as a signaling device. Nordic Journal of Political Economy. 27, 3-12. 12. Dalen, D.M. (2000): Catching-up investment without regulatory commitment. Journal of Regulatory Economics. 18, 133-150. 13. Dalen, D.M. (1998): Yardstick Competition and Investment Incentives. Journal of Economics & Management Strategy. 7, 105-126. 14. Grytten, J and D.M. Dalen (1998): Too many for too few: Efficiency in the Norwegian dental care industry. Journal of Health Economics. 16, 483-497. 15. Dalen, D.M. and A. Gomez-Lobo (1997): Estimating cost functions in regulated industries characterized by asymmetric information. European Economic Review. 41, 935-942. Invited paper at the Annual Congress of the European Economic Association, Istanbul, August 1996. 16. Dalen, D.M. (1997): Regulation of Quality and the Ratchet Effect: Does unverifiability hurt the regulator? Journal of Regulatory Economics. 11, 139-156. 17. Dalen, D.M. (1996): Strategic Responses to Relative Evaluation of Bureaus: 4
Implication for Bureaucratic Slack. Journal of Productivity Analysis,7, 29-39 18. Dalen, D.M. (1995): Efficiency-improving Investments and The Ratchet Effect. European Economic Reveiw.39, 1511-1522. In Norwegian 18. Markedsmakt og innovasjon på norsk sokkel (with Michael Hoel and Steinar Strøm). Samfunnsøkonomen. 3/2011. 19. D.M. Dalen (2009): Sykehusenes legemiddelanbud. Konkurranse på hvilke vilkår? Samfunnsøkonomen. 8/2009. 20. Kalkulasjonsrenten på lang sikt i en usikker verden (with Michael Hoel and Steinar Strøm). Samfunnsøkonomen. 8/2008. 21. D. M. Dalen, E. R. Moen, C. Riis (2007): Regulering av fjernvarme. Forskningsrapport nr.14. Handelshøyskolen BI. 06/2007 22. På like vilkår? En analyse av konkurranse mellom offentlige og private foretak (with Trond Bjørnenak, Dag Morten Dalen, Trond E. Olsen and Gaute Torsvik), Økonomisk Forum 1/2006. 23. D.M. Dalen and C. Riis (2005): Konkurranse for innovasjon. Ministry of Modernization. 24. På like vilkår? En analyse av konkurranse mellom offentlige og private foretak (Competition between public and private companies) (with Trond Bjørnenak, Dag Morten Dalen, Trond E. Olsen and Gaute Torsvik), Skrifter fra Konkurransetilsynet nr. 1/2005, Oslo: Norwegian Competition Authority. 25. D.M. Dalen, O. Lædre and C. Riis (2004): Statlig styring av prosjektledelse. Frischsenteret. Rapport 5/2004. 26. D.M. Dalen and S. Strøm (2004): Pris- og avanseregulering for legemidler. Frischsenteret. Rapport 4/2004. 27. D.M. Dalen and N-H. M von der Fehr (2003): Økonomiske prinsipper for fastsettelse av priser for jernbaneinfrastruktur. Frischsenteret. Rapport 3/2003. 28. Regulatory competition and multi-national banking. CESifo Working Paper No. 971. June 2003. (co-author Trond E. Olsen, NHH). 29. D.M. Dalen (2003): Legemiddelmarkedet etter apotekreformen. HERO Skriftserie 2003:1 5
30. D.M. Dalen, J. Grytten and R. Sørensen (2002): Mer penger eller mer for pengene? Organisering og finansiering av norske sykehus. Forskningsrapport nr.16. Handelshøyskolen BI. 31. D.M. Dalen (2002): Kan konkurranse bidra til lavere legemiddelpriser?. Forskningsrapport nr.14. Handelshøyskolen BI. 32. Sørensen, R. and D.M. Dalen (2001): Eierskap og tilknytningsformer i offentlig sektor. Forskningsrapport nr.9. Handelshøyskolen BI. 33. Dalen, D.M. (2001): Refomer i helsesektoren - politikk og økonomisk realiteter. Tidsskrift for helse, medisin og teknikk. Nr.1. 34. Dalen, D.M. and A. J. Lund (2001): Håndtering av finansielle kriser: Norges Banks rolle. Økonomisk Forum. 35. Dalen, D.M. (2000): Regulering og international regelverkskonkurranse i finansnæringen. NOU 2000:9 Vedlegg 4. 36. Dalen, D.M. (2000): Konkurranseutsetting av offentlige tjenester: Eierskap, kontrakter og konkurranse. Sosialøkonomen, 54, 23-28. 37. Dalen, D.M. og J. Vislie (1997): Konkurranseforhold, etablering og distribusjon i markedet for legemidler. SNF-rapport 1/97. Research visits University of California, Berkeley, March-April 2008. Department of Economics, University of Chile, March 2001. Visiting Scholar at Institute d Economie Industrielle (IDEI), Toulouse, France, 1994-95. Other activities Peer review team member for Association to Advance Collegiate Schools of Business (AACSB). 2015. Member of the National Committee for Evaluation of Professorships in Economics. 2007-2009. Member of doctoral committee. UiO. 2009. Member of doctoral committee. NHH. 2008. Member of doctoral committee. UiO. 2005. 6
Member of doctoral committee. NTNU. 2003. 7